Perimenopause-Related Mood and Behavioral Disorders: study

	Tweet

The purpose of this study is to investigate mood and behavior changes in the time period surrounding and including menopause. This is an observational study; volunteers who participate will not receive any new or experimental therapies.

Controversy exists regarding the relationship between estrogen and progesterone (gonadal steroid) changes and midlife-onset depression. This study will examine the role of gonadal steroids in perimenopausal mood and behavioral disorders. 

Perimenopausal women with depression symptoms and a control group of healthy perimenopausal volunteers will be compared to identify correlates of the occurrence of depression. Participants with depressive symptoms may also participate in companion studies that will test the antidepressant efficacy of phytoestrogens and selective estrogen receptor modulators (SERMS).

A group of younger pre-perimenopausal women with normal menstrual cycle functioning will be followed through menopause in an effort to confirm the association of depression onset with changes in reproductive endocrine functioning.

Controversy exists regarding the relevance of changes in gonadal steroids for midlife onset depressions. In this protocol, we examine the possible role of gonadal steroids in these disorders in two ways. First, we identify groups of both depressed and asymptomatic women who are in the perimenopause (as defined endocrinologically).

Patients and controls are compared using baseline biological and phenomenological (e.g. life events, hot flushes) measures in an attempt to identify potentially meaningful correlates of the occurrence of depression.

Patient subjects also serve as participants in companion protocols designed to identify the antidepressant efficacy of estradiol and DHEA administration. Second, we identify younger preperimenopausal women with normal menstrual cycle function, who are followed longitudinally through the menopause in an effort to confirm the association of depression onset with change in reproductive endocrine function. This protocol, then, serves as a screening protocol to recruit subjects who are characterized with standard measures in this protocol and then offered participation in related studies.

Sponsored by:  National Institute of Mental Health (NIMH)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001231

RELATED STORIES:
Pill Among Least Effective Birth Control Methods   70 percent of women use contraceptives during their first sexual encounter   Long-term contraception more effective than pills   Gay couples and women over 40 to get free IVF treatment on NHS   Health secretary urges contraception compromise   Contraceptive ring, patch carry blood clot risks   Reminder Stamp Boosts HPV Vaccination   Study adds to evidence on clot risks of non-oral contraceptives   HPV vaccine completion rate among girls is poor, getting worse   Some ob-gyns cite religious conflicts over care   After IVF, some couples get pregnant without help   Web Tool Offers Map to Menopause   Early Menopause Could Also Mean Early Death   Does soy help cool hot flashes after all?   Caffeine not tied to worsening urinary incontinence

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]